More News! 14 Oct 2022
ChristianaCare spins out new gene-editing company CorriXR Therapeutics
…said Janice Nevin, ChristianaCare president and CEO. The company has developed CRISPR/Cas biomolecular tools that disable the genome of a tumor cell but not the genome of a healthy cell,…